Press Releases

Date   Headline
Nov 13, 2014 Cleveland BioLabs and Roswell Park Cancer Institute Announce Publication of Studies Demonstrating Curaxin CBL0137's Ability to Eradicate Drug-Resistant Cancer Stem Cells and Potentiate Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
Nov 05, 2014 Cleveland BioLabs Reports Third Quarter 2014 Financial Results and Development Progress
Nov 04, 2014 Cleveland BioLabs to Host Third Quarter 2014 Earnings Conference Call and Webcast Live on Wednesday, November 5, 2014
Oct 28, 2014 Cleveland BioLabs to Report Third Quarter 2014 Financial Results and Provide Operational Update on November 5
Sep 15, 2014 Cleveland BioLabs Announces Approval to Start Phase 1 Study for Hematopoietic Stem Cell Mobilizer CBLB612 in Russian Federation
Sep 08, 2014 Cleveland BioLabs and Sabby Announce Resolution of Litigation
Sep 03, 2014 Cleveland BioLabs Announces Green Light to Submit Pre-Emergency Use Authorization Application for Entolimod
Sep 02, 2014 Cleveland BioLabs to Report Outcome of July FDA Meeting and Host Conference Call on September 3
Sep 02, 2014 Cleveland BioLabs to Present at Rodman & Renshaw 16th Annual Global Investment Conference
Aug 07, 2014 Cleveland BioLabs Reports Second Quarter 2014 Financial Results and Development Progress
Aug 06, 2014 Cleveland BioLabs to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 7, 2014
Jul 29, 2014 Cleveland BioLabs to Report Second Quarter 2014 Financial Results and Provide Operational Update on August 7
Jun 18, 2014 Cleveland BioLabs Reduces Debt With $3.5 Million At-the-Market Private Placement of Unregistered Stock
May 09, 2014 Cleveland BioLabs Announces Compensation Reductions for Co-Founders and Directors; New Board Nominees
May 08, 2014 Cleveland BioLabs Reports First Quarter 2014 Financial Results and Development Progress
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue